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Background:MIC determination has became easier, with intro-
duction of the E-test. The point of contention has been the cost of
the commercial strips which has restricted its use in resource lim-
ited countries. We attempted to develop, standardize and validate
a simple in – house agar gradient method, to determine MIC of
vancomycin for clinical isolates of S. aureus.
Methods & Materials: In – house strips were made from What-
mann ﬁlter paper no 1. The strips were impregnated with varying
concentration of vancomycin solution so as to create an increas-
ing antibiotic gradient along the strip. During the standardization
step, MIC’s of 90 clinical strains of S. aureus and ATCC 29213 were
tested by the broth microdilution and commercial strip followed
by the in – house strip. The results were kept blinded during the
development stage. Variables for the preliminary considerations
for optimization and standardization of the In – House Agar Gradi-
ent strip were considered to correct the outliers. This was followed
by validation stage where MIC’s of 90 different clinical strains of
S. aureus and ATCC 29213 were determined by the in – house and
results were kept blinded. This was followed by determination of
MIC’s by broth microdilution and commercial strips. An MIC read-
ing of ± 1log2 dilution compared with broth microdilution was
considered as an outlier
Results: During the optimization and standardization stage
there were 7/90 outliers in the clinical strains and no outliers
seen with the ATCC 29213 control strain. Corrective action was
performed by increasing precaution during the antibiotic solution
impregnation stage. During the validation stage, only 4/90 outliers
were observed in the clinical strains. The commercial strips had
29/90 among clinical and 15/30 outliers in the control strain dur-
ing the prevalidation phase. The supplierwas informed tomaintain
cold chain and during the validation phase the outliers for com-
mercial strip were 18/90 and 4/30 in the clinical and control strain
respectively.
Conclusion: Vancomycin sensitivity is reported as MIC. Expen-
sive commercial strips can be replaced by in – house strips using
this simple technique after validating it with a gold standard
method like broth microdilution.
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Background: Multidrug-resistant (MDR) Gram-negative bacte-
rial pathogens, often resistant to more than one class of antibiotics
including carbapenems and aminoglycosides, pose serious threats
in healthcare settings worldwide. A 2015 White House task force
issued guidelines to combat antibiotic-resistant strains in the
United States, which the Center for Diseases Center has termed
“nightmare bacteria”. MDR pathogens cause at least two million
illnesses and 23,000 deaths annually in the U.S. MDR A. bauman-
nii (MDR-Ab) cause 10% of hospital-acquired infections (HAI) with
70% patient mortality. A mini-outbreak of carbapenem-resistant
(CR)MDR-Ab (CR-MDR-Ab) occurredduringa2009-2010H1N1epi-
demic at CarilionMedical Center (CMC) in Virginia, U.S; three of the
nine patients died. To develop effective strategies for prevention,
control and treatment of MDR infections, we are performing whole
genome analysis of the clinical isolates of CR-MDR-Ab.
Methods & Materials: To date, we have analyzed 68 Ab clini-
cal isolates, including ﬁve CR-MDR-Ab outbreak strains. We have
sequenced and analyzed whole genomes of the following MDR-
Ab isolates: an isolate from outbreak patients (CMC-MDR-Ab4); a
carbapenem-sensitive isolate (CMC-MDR-Ab59); and aCR-MDR-Ab
(CMC-MDR-Ab66) isolate from sporadic cases. The sequencing was
performed on the PacBioRSII platform.
Results: The CR CMC-MDR-Ab strains were found to carry two
plasmids, pCMCVTAb1 and pCMCVTAb2. The latter is conjuga-
tive type and carried two transposons: Tn2008-like, containing a
beta-lactamase gene (blaOXA23) and conferring CR, and a TnaphA6
element causing aminoglycoside resistance and further reducing
treatment choices. Their chromosomes carried ﬁve bla genes and
an aphA1 gene. A PCR analysis based upon the resistant determi-
nants showed that all outbreak isolates (100%) carried pCMCVTAb2
containing the two transposons. Fourteen of the remaining 63
isolates (22.22%) carried pCMCVTAb2 and of these, six (42.85%)
carried Tn2008-like, and two (14.28%) carried TnaphA6. These dif-
ferences are statistically signiﬁcant using Fisher’s exact, two-tailed
p=0.0011, p =0.0445 and p=0.0018.
Conclusion: The results suggested that pCMCVTAb2 was
responsible for the CR-MDR outbreak. A PCR analysis based on the
antibiotic-resistant genes of pCMCVTAb2 could be used for rapid
identiﬁcation of CR-MDR-Ab strains, thereby helping to prevent the
